Intra-abdominal and pelvic emergencies

Medical Clinics of North America

Volumn 96, Issue 6, 2012, Pages 1171-1191

  Singh, Sushma ^a   Khardori, Nancy Misri ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Intra abdominal emergencies; Intra abdominal infections; Pelvic emergencies; Peritonitis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZTREONAM; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANATE POTASSIUM PLUS TICARCILLIN; COTRIMOXAZOLE; DORIPENEM; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; NORFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAXIMIN; SULTAMICILLIN; TICARCILLIN; TIGECYCLINE; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ABDOMINAL ABSCESS; ABDOMINAL INFECTION; ACUTE CHOLECYSTITIS; ANTIBIOTIC THERAPY; BACTERIAL PERITONITIS; BILIARY TRACT INFECTION; CAMPYLOBACTERIOSIS; CHOLANGITIS; CHOLECYSTITIS; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; ENTEROCOLITIS; FEVER; HUMAN; INTRAPERITONEAL ABSCESS; LIVER ABSCESS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATHOPHYSIOLOGY; PERIRENAL ABSCESS; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; PYELONEPHRITIS; RETROPERITONEAL ABSCESS; REVIEW; SHIGELLOSIS; SMALL INTESTINE OBSTRUCTION; SPLEEN ABSCESS; SUBPHRENIC ABSCESS; TREATMENT INDICATION;

ABDOMINAL ABSCESS; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; DIGESTIVE SYSTEM; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DRAINAGE; DRUG RESISTANCE, MICROBIAL; EMERGENCY TREATMENT; HUMANS; INTRAABDOMINAL INFECTIONS; PERITONITIS;

EID: 84868108987     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.09.002     Document Type: Review

References (71)

1. Levison ME, Bush LM. Intra-Abdominal Infection. Mandell, Douglas and Bennett's Principles and Practice of Infectious Disease, 7th edition. Section F; Chapter 71:1011.
2. Liles WC, Dellinger EP. Infectious diseases; The Clinician's Guide to Diagnosis, Treatment and Prevention online version. Sept 2009; Infectious syndromes: chapter on Intra-Abdominal abscesses.
3. Ranji S.R., Goldman L.E., Simel D.L., et al. Do opiates affect the clinical evaluation of patients with acute abdominal pain?. JAMA 2006, 296(14):1764-1774.
4. Cartwright S.L., Knudson M.P. Evaluation of acute abdominal pain in adults. Am Fam Physician 2008, 77(7):971-978.
5. Lyon C., Clark D.C. Diagnosis of acute abdominal pain in older patients. Am Fam Physician 2006, 74(9):1537-1544.
6. Nathens A.B., Rotstein O.D., Marshall J.C. Tertiary peritonitis: clinical features of a complex nosocomial infection. World J Surg 1998, 22:158-163.
7. Wiest R., Krag A., Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut 2012, 61(2):297-310.
8. Mowat C., Stanley A.J. Spontaneous bacterial peritonitis- diagnosis, treatment and prevention. Aliment Pharmacol Ther 2001, 15:1851-1859.
9. Wiest R., Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005, 41:422-433.
10. Wilcox C.M., Dismukes W.E. Spontaneous bacterial peritonitis: a review of pathogenesis, diagnosis and treatment. Medicine (Baltimore) 1987, 66:447-456.
11. Reuken P.A., Pletz M.W., Baier M., et al. Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study. Aliment Pharmacol Ther 2012, 35(10):1199-1208.
12. Jafferbhoy H.M., Miller M.H., Gashau W., et al. Spontaneous bacterial peritonitis prophylaxis in the era of healthcare associated infection. Gut 2012.
13. Soared-Weiser K., Paul M., Beegs M. Evidence based case report. Antibiotic treatment for spontaneous bacterial peritonitis. BMJ 2002, 324:100-103.
14. Runyon B.A., McHutchison J.G., Antillon M.R., et al. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis: a randomized controlled study of 108 patients. Gastroenterology 1991, 100:1737-1742.
15. Hanouneh M.A., Hanouneh I.A., Hashash J.G., et al. The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis. J Clin Gastroenterol 2012, 46(8):709-715.
16. Wilson S.E., Hopkins J.A. Clinical correlates of anaerobic bacteriology in peritonitis. Clin Infect Dis 1995, 20(Suppl 2):S251.
17. Blot S., De Waele J.J., Vogelaers D. Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs 2012, 72(6):e17-e32.
18. Patterson H.C. Left subphrenic abscess. Am Surg 1977, 43:430-433.
19. Saini S., Kellum J.M., O'Leary M.P., et al. Improved localization and survival in patients with intra-abdominal abscesses. Am J Surg 1983, 145:136-142.
20. Brook I., Frazier E.H. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J Med Microbiol 2000, 49:827.
21. Swenson R.M., Lorber B., Michaelson T.C., et al. The bacteriology of intra-abdominal infections. Arch Surg 1974, 109:398.
22. Altemeier W.A., Culbertson W.R., Fullen W.D., et al. Intra- abdominal abscesses. Am J Surg 1973, 125:70-79.
23. Samuelsson A., Isaksson B., Jonasson J., et al. Changes in the aerobic faecal flora of patients treated with antibiotics for acute intra-abdominal infection. Scand J Infect Dis 2012, 25:1-8.
24. Oteo J., Domingo-García D., Fernández-Romero S. Abdominal abscess due to NDM-1-producing Klebsiella pneumoniae in Spain. J Med Microbiol 2012, 61:864-867.
25. Milne G.A., Geere I.W. Chronic subphrenic abscess: the missed diagnosis. Can J Surg 1977, 20:162-165.
26. Connell T.R., Stephens D.H., Carlson H.C., et al. Upper abdominal abscess: a continuing and deadly problem. AJR Am J Roentgenol 1980, 134:759-765.
27. Mueller P.R., Simeone J.F. Intra-abdominal abscesses: diagnosis by sonography and computed tomography. Radiol Clin North Am 1983, 21:425-443.
28. Gupta H., Dupuy D.E. Advances in imaging of the acute abdomen. Surg Clin North Am 1997, 77:1245.
29. Montgomery R.S., Wilson S.E. Intraabdominal abscesses: image-guided diagnosis and therapy. Clin Infect Dis 1996, 23:28-36.
30. Branum G.D., Tyson G.S., Branum M.A., et al. Hepatic abscess. Changes in aetiology, diagnosis, and management. Ann Surg 1990, 212(6):655-662.
31. Men S., Akhan O., Köroĝlu M. Percutaneous drainage of abdominal abscess. Eur J Radiol 2002, 43(3):204-218.
32. Styrud J., Eriksson S., Nilsson I., et al. Appendectomy versus antibiotic treatment in acute appendicitis: a prospective multicenter randomized controlled trial. World J Surg 2006, 30:1033-1037.
33. Vons C., Barry C., Maitre S., et al. Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute appendicitis: an open-label, non-inferiority, randomised controlled trial. Lancet 2011, 377:1573-1579.
34. Seymour N.E., Bell R.L. Abdominal Wall, Omentum, Mesentery, and Retroperitoneum. Schwartz's Principles of Surgery 2010, McGraw-Hill, New York. 9th ed. F.C. Brunicardi, D.K. Andersen, T.R. Billiar (Eds.).
35. Johannsen E.C., Sifri C.D., Madoff L.C. Pyogenic liver abscesses. Infect Dis Clin North Am 2000, 14:547.
36. Winkelstein J.A., Marino M.C., Johnston R.B., et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore) 2000, 79:155.
37. Lublin M., Bartlett D.L., Danforth D.N., et al. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg 2002, 235:383.
38. Thanos L., Dailiana T., Papaioannou G., et al. Percutaneous CT-guided drainage of splenic abscess. AJR Am J Roentgenol 2002, 179:629.
39. Indar A.A., Beckingham I.J. Acute cholecystitis. BMJ 2002, 325(7365):639-643.
40. Shapiro M.J., Luchtefeld W.B., Kurzweil S., et al. Acute acalculous cholecystitis in the critically ill. Am Surg 1994, 60:335-339.
41. RaIls P.W., Halls J., Lapin S.A., et al. Prospective evaluation of the sonographic Murphy sign in suspected acute cholecystitis. J Clin Ultrasound 1982, 1:113-115.
42. Merriam L.T., Kanaan S.A., Dawes L.G., et al. Gangrenous cholecystitis: analysis of risk factors and experience with laparoscopic cholecystectomy. Surgery 1999, 126:680-685.
43. Stefanidis D., Bingener J., Richards M., et al. Gangrenous cholecystitis in the decade before and after the introduction of laparoscopic cholecystectomy. JSLS 2005, 9:169-173.
44. Yokoe M., Takada T., Strasberg S.M., et al. New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo guidelines. J Hepatobiliary Pancreat Sci 2012, 19(5):578-585.
45. Kiewiet J.J., Leeuwenburgh M.M., Bipat S., et al. A systematic review and meta-analysis of diagnostic performance of imaging in acute cholecystitis. Radiology 2012, 264(3):708-720.
46. Marcos L.A., Terashima A., Gotuzzo E. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis 2008, 21:523-530.
47. Wada K., Takada T., Kawarada Y., et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg 2007, 14:52-58.
48. Sharma B.C., Agarwal D.K., Baijal S.S., et al. Endoscopic management of acute calculous cholangitis. J Gastroenterol Hepatol 1997, 12:874-876.
49. Everhart J.E., Ruhl C.E. Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. Gastroenterology 2009, 136:741-754.
50. Navaneethan U., Giannella R.A. Infectious colitis. Curr Opin Gastroenterol 2011, 27:66-71.
51. Maki D.G. Coming to grips with foodborne infection: peanut butter, peppers and nationwide salmonella outbreaks. N Engl J Med 2009, 360:949-953.
52. Gradel K.O., Nielsen H.L., Schønheyder H.C., et al. Increased short- and long term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis. Gastroenterology 2009, 137:495-501.
53. Lindberg A.A., Pal T. Strategies for development of potential candidate Shigella vaccines. Vaccine 1993, 11:168-179.
54. Prince Christopher R.H., David K.V., John S.M., et al. Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev 2010, (1). CD006784.
55. Ternhag A., Torner A., Svensson A., et al. Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis 2008, 14:143-148.
56. Marshall J.K., Thabane M., Garg A.X., et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010, 59:605-611.
57. Edelman R., Karmali M.A., Fleming P.A. Summary of the International Symposium and Workshop on Infections due to Verocytotoxin (Shiga-like toxin)-producing Escherichia coli. J Infect Dis 1988, 157:1102-1104.
58. Stanley S.L. Amoebiasis. Lancet 2003, 361:1025-1034.
59. Haque R., Mollah N.U., Ali I.K., et al. Diagnosis of amebic liver abscess and intestinal infection with the TechLab Entamoeba histolytica II antigen detection and antibody tests. J Clin Microbiol 2000, 38:3235-3239.
60. Cohen S.H., Gerding D.N., Johnson S., Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31(5):431-455.
61. Moudgal V., Sobel J.D. Clostridium difficile colitis: a review. Hosp Pract (Minneap) 2012, 40(1):139-148.
62. McDonald L.C., Killgore G.E., Thompson A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353(23):2433-2441.
63. Zar F.A., Bakkanagari S.R., Moorthi K.M., et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007, 45(3):302-307.
64. Louie T.J., Miller M.A., Mullane K.M., et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011, 364(5):422-431. OPT-80-003 Clinical Study Group.
65. Lamontagne F., Labbé A.C., Haeck O., et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 2007, 245(2):267-272.
66. Pinson A.G., Philbrick J.T., Lindbeck G.H. Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med 1997, 15:148.
67. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002, 113(Suppl 1A):14S-19S.
68. Lopez-Medrano F., Garcia-Bravo M., Morales J.M., et al. Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: an underdiagnosed etiology for obstructive uropathy and graft dysfunction-results of a prospective cohort study. Clin Infect Dis 2008, 46:825-830.
69. Gupta K., Hooton T.M., Naber K.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52(5):e103-e120.
70. Sandberg T., Skoog G., Hermansson A.B., et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet 2012, 380(9840):484-490.
71. Gerzof S.G., Gale M.E. Computed tomography and ultrasonography for diagnosis and treatment of renal and retroperitoneal abscesses. Urol Clin North Am 1982, 9:185-193.